Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Powerfleet Announces Board and Audit Committee Transition
-
AAR reports fourth quarter and fiscal year 2026 results
-
TrueBlue to Announce Second Quarter 2026 Results
-
AMERISAFE Announces 2026 Second Quarter Results
-
Supermicro Provides Fourth Quarter of Fiscal Year 2026 Preliminary Business Update
-
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
-
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
-
East West Bancorp Reports Second Quarter 2026 Results, With Earnings Per Share Up 18% Year-Over-Year, Driven by Record Total Revenue
-
Coupang to Announce Second Quarter 2026 Results on August 4, 2026
-
Docebo Inc. Announces Commencement of Previously Announced Substantial Issuer Bid
-
Chubb Reports Second Quarter Per Share Net Income of $7.30 and Per Share Core Operating Income of $7.26, Up 18.2%; Consolidated Net Premiums Written of $14.7 Billion, Up 3.6%, with P&C and Life In
-
Pega Drives Cash Flow and Releases AI Innovation in Q2 2026
-
Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
-
Paramount Declares Quarterly Cash Dividend
-
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
-
Zeta Global to Announce Second Quarter 2026 Results on August 4, 2026
-
Rocky Brands, Inc. to Report Second Quarter 2026 Results on July 28, 2026
-
Innovex International, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call
-
Solid Power, Inc. Announces Timing of Second Quarter 2026 Earnings Release and Conference Call
-
Viant to Participate in Upcoming Investor Conferences
-
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
-
Finance of America Announces Second Quarter 2026 Earnings Release and Conference Call on August 4, 2026
-
Toast Announces Release Date Of Second Quarter 2026 Financial Results
-
EVERTEC to Announce Second Quarter 2026 Financial Results on August 4, 2026
-
Tigo Energy Inc. to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 at 4:30 p.m. ET
-
ROLLINS, INC. ANNOUNCES REGULAR QUARTERLY CASH DIVIDEND
-
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
-
Superior Group of Companies to Announce Second Quarter 2026 Results
-
Getty Realty Corp. Announces Regular Quarterly Cash Dividend
-
Cipher Digital Announces Date of Second Quarter 2026 Business Update Conference Call
-
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
-
The Honest Company To Report Second Quarter 2026 Financial Results on August 5, 2026
-
First Advantage Named to TIME’s 2026 List of America’s Best Companies
-
Inspired to Report Second Quarter 2026 Results and Hold Conference Call on August 6th
-
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
-
First Advantage Named to TIME’s 2026 List of America’s Best Companies
-
Solo Brands, Inc. Fiscal 2026 Second Quarter Results To Be Released Thursday, August 13, 2026
-
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
-
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
-
Valley National Bancorp Declares its Regular Quarterly Preferred and Common Stock Dividends
-
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
-
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
YANKTON COUNTY SHERIFF'S DEPUTIES VOTE UNANIMOUSLY FOR TEAMSTERS REPRESENTATION
-
Upwork to Report Second Quarter Financial Results on August 10, 2026
-
Harmony Acquisitions Announces Board and Management Changes and Cancellation of Stock Options
-
FVCBankcorp, Inc. Announces Record Earnings; 45% Increase in Net Income Compared to Year Ago Quarter
-
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
-
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunolo
-
Interactive Brokers Group Announces 2Q2026 Results
-
PARAMOUNT TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 4, 2026
